About: 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • karcinom prsu, HER2/Neu, transtuzumab, paklitaxel (cs)
  • breast cancer, HER2/Neu overexpression, transtuzumab, paklitaxel
  • breast cancer, HER2/Neu overexpression, transtuzumab, paklitaxel (en)
Title
  • Výsledky 4-letého užívání trastuzumabu a paklitaxelu v týdením režimu v léčbě žen s karcinomem prsu se zvýšenou expresí HER2/Neu genu: prospektivní studie (cs)
  • 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study
  • 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study (en)
skos:prefLabel
  • Výsledky 4-letého užívání trastuzumabu a paklitaxelu v týdením režimu v léčbě žen s karcinomem prsu se zvýšenou expresí HER2/Neu genu: prospektivní studie (cs)
  • 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study
  • 4- years results of weekly trastuzumab and paklitaxel in the treatment with women with HER2/neu overexpressing advanced breast cancor: singl prospective study (en)
skos:notation
  • RIV/00216208:11110/04:00009316!RIV08-MSM-11110___
http://linked.open.../vavai/riv/strany
  • 279;283
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • V
http://linked.open...iv/cisloPeriodika
  • 10
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 596685
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11110/04:00009316
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • years; results; weekly; trastuzumab; paklitaxel; treatment; women; HER2/neu; overexpressing; advanced; breast; cancor; singl; prospective; study (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • FR - Francouzská republika
http://linked.open...ontrolniKodProRIV
  • [4ED97081556A]
http://linked.open...i/riv/nazevZdroje
  • Bulletin du Cancer
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 91
http://linked.open...iv/tvurceVysledku
  • Petruželka, Luboš
  • Zimovjanová, Martina
  • Janků, Filip
  • Přibylová, Olga
  • Šafanda, Martin
  • Pazdrová, Gabriela
issn
  • 0007-4551
number of pages
http://localhost/t...ganizacniJednotka
  • 11110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 112 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software